Hybrigenics Inks Equity Facility Deal with Yorkville | GenomeWeb

NEW YORK (GenomeWeb News) – Hybrigenics, a French biopharmaceutical and life science tools firm, has signed a three-year equity facility agreement with Yorkville Advisors, under which Hybrigenics could receive up to €5 million ($7.3 million).

The equity facility is subject to approval at the next extraordinary general meeting of Hybrigenics, which is expected to be called on Oct. 23, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.